F 0694
Provide for the safe, appropriate administration of IV fluids for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to ensure parenteral care and services were
administered consistent with professional standards of practice for 2 of 3 residents reviewed for intravenous
fluids. (Resident #39 and 82)
Residents Affected - Few
*The facility failed to change Resident #39 and 82's midline catheter dressing in accordance with the
resident's plan of care. (Midline catheter is an ultrasound guided catheter inserted in the upper arm
peripheral veins for IV access)
This failure could place residents at risk of not receiving the appropriate IV care and services.
Findings included:
1. Record review of physician orders dated April 2023 indicated Resident #39, admitted [DATE], was [AGE]
years old with diagnoses of emphysema and COPD (chronic obstructive pulmonary disease).
Record review of a physician order dated 04/13/23 for Resident #39 indicated Midline catheter to right arm change sterile transparent dressing to insertion site using sterile technique Q (every) weekly and PRN (as
needed) if wet, soiled, or not intact. Resident #39 was to receive Cefepime HCL (hydrochloride) Intravenous
solution 1 GM/50 ml. Use 1 GM intravenously every 12 hours for pneumonia for 7 days.
Record review of Resident #39's TAR (treatment administration record) for April 2023 indicated Midline
catheter to right arm - change sterile transparent dressing to insertion site using sterile technique Q (every)
weekly and PRN (as needed) if wet, soiled, or not intact. There was no indication Resident #39's midline
catheter site dressing had been changed since insertion on 04/15/23 and was not scheduled to be changed
until 04/23/23.
Record review of Resident #39's quarterly MDS dated [DATE] gave no indication of midline IV or IV
antibiotics, as this MDS was completed prior to new orders.
Observation and interview on 04/17/23 at 8:30 a.m., Resident #39 had a right upper arm midline IV with an
undated, soiled transparent dressing. A piece of dried, blood-tinged gauze was under the transparent
dressing. Resident #39 said the midline IV was put in a few days ago and was receiving antibiotics. He
denied any pain or swelling at site.
Observation and interview on 04/17/23 at 12:49 p.m., LVN C said Resident #39's midline IV was inserted
04/15/23. She said the transparent dressing was not signed and dated and it should be. She said
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
675540
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675540
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Liberty Health Care Center
1206 N Travis St
Liberty, TX 77575
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0694
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
RNs are responsible for changing the midline IV dressing weekly. LVN C said Resident #39's IV dressing
needed to be changed because it had dried blood under it. She said nursing staff needed to be able to
always assess the IV site, and Resident #39's site could not be assessed because of the dried,
blood-stained gauze. She added a soiled dressing such as the one on Resident #39 could potentially cause
an infection. LVN C said the site was to be assessed for signs of infection, which included redness, warmth,
and drainage.
Observation and interview on 04/18/23 at 12:00 p.m. with Regional Nurse at Resident #39's bedside. He
said the midline IV catheter was inserted on 04/15/23 by an outside vendor, and the dressing site should
have been dated and initialed at that time. He said the IV site should not have dried blood under the
dressing, and the dressing should have been changed 24-48 hours after insertion, and it did not appear to
have been changed per policy. Regional Nurse said midline IV sites should also have dressing changes
when visibly soiled and PRN (as needed). He said the treatment nurse, who was an RN, was responsible
for midline IV dressing changes.
During an interview on 04/18/23 at 12:15 p.m., DON said her expectations were IV sites to be assessed
and dressing changes performed per facility policy. She said Resident #39's midline IV site dressing should
have been changed due to soiled dressing. She added this oversight could potentially lead to an infection of
the site.
2. Record review of admission physician orders dated 04/10/23 indicated Resident #82, admitted [DATE],
was [AGE] years old with diagnosis of Sepsis (a serious condition resulting from the presence of harmful
microorganisms in the blood or other tissues).
Record review of a physician order dated 04/11/23 for Resident #82 indicated Midline catheter to right arm change sterile transparent dressing to insertion site using sterile technique Q (every) weekly and PRN (as
needed) if wet, soiled, or not intact. Resident #82 was to receive cefazolin sodium (used to treat bacterial
infections) intravenously. Use 2 GM intravenously every 8 hours for infection until 05/09/23.
Record review of Resident #82's TAR (treatment administration record) for April 2023 indicated Midline
catheter to right arm - change sterile transparent dressing to insertion site using sterile technique Q (every)
weekly and PRN (as needed) if wet, soiled, or not intact. Resident #39's midline catheter site dressing had
been changed on Sunday 04/16/23, however on this date Resident #82's midline RUA dressing was
compromised as it was soiled with dried blood under the transparent dressing.
Record review of Resident #82's admission MDS dated [DATE] indicated receiving IV antibiotic medications
prior to admission to facility and while in the facility.
Record review of Resident #82's care plan dated 04/12/23 gave indication of a midline IV access site.
Resident #82's goal was to have no complications related to IV therapy through the next review.
Interventions for Resident #82 included changing sterile transparent dressing per physician order and as
needed if integrity of dressing is compromised (wet, loose, or soiled). Use a transparent dressing to ensure
visualization of the IV site.
During observation and interview on 04/19/23 at 2:00 p.m., Resident #82 was sitting in wheelchair visiting
with spouse. Resident #82 had a RUA midline IV catheter with a soiled transparent dressing. His had dried
blood visible through the transparent dressing. Resident #82 said his IV site dressing had been changed
over the weekend. The initials and date were illegible. Resident #82 denied pain
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675540
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675540
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Liberty Health Care Center
1206 N Travis St
Liberty, TX 77575
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0694
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
or swelling at site. He said he was receiving IV antibiotics for a skin condition. He said he did not know how
long the dried blood had been under the transparent dressing.
During an observation and interview on 04/19/23 at 2:10 p.m., LVN C acknowledged Resident #82's midline
IV dressing was soiled and needed to be changed. She said she would notify the treatment nurse of the
situation.
During an interview on 04/19/23 at 10:20 a.m., the treatment nurse said she worked Monday-Friday and
was responsible for all wound care including IV site dressing changes. She said on the weekends, the
weekend RNs were responsible for wound care. The treatment nurse said she had worked at the facility for
2 years and had been the treatment nurse since August 2022. She said she had received training via online
classes and hands-on training. She said the nursing staff were scheduled for an in-service training the
following day (04/20/23). The treatment nurse said she was supposed to be notified of any new wound/IV
orders. She also receives a daily computer print-out of new and/or current wounds and orders.
Record review of training in-service indicated most recent in-service on wound care and dressing changes
was December 2022 and provided by DON/Regional nurse.
Record review of a facility policy dated revised April 2016 and titled, Midline Dressing Changes indicated: .
Purpose: The purpose of this procedure is to prevent catheter-related infections associated with
contaminated, loosened, or soiled catheter site dressings. General Guidelines. 1. Change midline catheter
dressing 24 hours after catheter insertion, every 5-7 days, or if it is wet, dirty, not intact, or compromised in
any way.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675540
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675540
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Liberty Health Care Center
1206 N Travis St
Liberty, TX 77575
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to establish a system of records of receipt and
disposition of all controlled drugs in sufficient detail to enable an accurate reconciliation and drug records
were in order and that an account of all controlled drugs was maintained for 1 of 18 residents (Resident
#46) reviewed for pharmacy services.
LVN A did not destroy the used fentanyl (scheduled II controlled medication used for severe pain) patch in a
sharps container per policy and with a witness for destruction after the patch was removed from Resident
#46.
The facility did not ensure records for Resident #46 were complete with witness signatures for 5 days on
control sheet for disposition of discarded fentanyl patch.
This failure could place the residents at risk of drug diversion.
Findings included:
Record Review of physician orders summary dated April 2023 indicated Resident #46 admitted [DATE] and
was [AGE] years old with diagnoses of chronic pain and kidney cancer. The orders indicated to apply 1
fentanyl patch 75 mcg/hour every 3 days and remove patch per schedule.
Record review of the significant change MDS assessment dated [DATE] indicated Resident #46 had
chronic pain and received pain medication routinely.
Record review of Resident #46 medication administration record dated April 2023 indicated a fentanyl patch
75 mcg/hour was ordered every 72 hours, applied transdermal (medication absorbed through the skin) and
removed after 72 hours for pain management on the following dates:
*04/6/23,
*04/9/23,
*04/12/23,
*04/15/23,
*and 04/18/23.
Record review of Resident #46's count sheet dated 03/31/23 indicated a fentanyl patch was applied and no
witness signatures to indicate the removed used fentanyl patch was destroyed with witnesses on the
following dates:
*04/6/23, nurse signature was illegible, when the patch was removed and no witness signed,
*04/9/23, an unnamed agency nurse signed removing patch and no witness signed,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675540
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675540
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Liberty Health Care Center
1206 N Travis St
Liberty, TX 77575
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
*04/12/23, LVN B signed removing patch and no witness signed,
Level of Harm - Minimal harm
or potential for actual harm
*04/15/23, LVN B signed removing patch and no witness signed,
*and 04/18/23, LVN A signed removing patch and no witness signed.
Residents Affected - Few
During an observation on 04/18/23 at 7:43 a.m., LVN A removed the fentanyl patch from Resident #46's
chest and placed in the resident's trash. She removed the resident's trash bag with the used fentanyl patch
in it, brought it to the soiled linen room, and placed into the trash can. The soiled linen room was not locked.
During an interview on 04/18/23 at 7:52 a.m., LVN A said she was trained to throw the fentanyl patch in the
trash, bring the trash bag out of the room, and dispose the fentanyl patch in the regular trash can. She said
the fentanyl patch could still have medication on the patch. LVN A said she would then sign on the control
sheet- sign that she placed a new patch and disposed of the old patch. LVN A denied getting another nurse
to witness her dispose of the fentanyl patch for Resident #46. She said she was not trained to use the
column which was labeled witness signature.
During an interview and record review on 04/18/23 at 8:15 a.m., the DON said she expected the nurses
who removed the used fentanyl patch to dispose it in the sharp's container with a witness and both sign the
count sheet. She pointed to the count sheet for Resident #46 and said the nurse who witnessed the patch
being placed in the sharp's container should have signed in column marked witness signature. The DON
said the witnesses did not sign Resident #46's sheet. She said she could not read the signature of the
nurse, who removed the patch on 04/06/23. The DON said the documentation on 04/09/23 was an agency
nurse.
During an interview on 04/18/23 at 8:18 a.m., the administrator said he agreed with the DON about the way
the control medication should be handled.
During an interview on 04/19/23 at 9:00 a.m., LVN B said on 04/12/23 and 04/15/23 she disposed of the
used fentanyl patch in the sharp's container on the medication cart for Resident #46. LVN B said she forgot
to get someone to witness her placing the patch in the sharps container and sign the control sheet. She
said if they did not get a witness, they could be accused of taking the used fentanyl patches. She said they
were trained to have a witness, when disposing of a used fentanyl patch.
During an interview on 04/19/23 at 2:00 p.m., the DON said per the facility's policy, the nurses must have a
witness to dispose of the fentanyl patch or any controlled medications to prevent drug diversion.
Record review of the policy Disposal of medications dated August 2014 . indicated Medications included in
the Drug Enforcement Administration classification as controlled substances are subject to special
handling, storage, disposal and recordkeeping in the facility in accordance with federal and state laws and
regulations. E. The witnesses of the destruction
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675540
If continuation sheet
Page 5 of 5